Licensing | BayPAT

Skip to page content

Choose Category:

BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA

Jul 15, 2019

BayPAT’s Licensee Recardio already in Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin in Europe and USA
BayPAT's Licensee Scintomics signed Sub-License Agreement

May 10, 2018

BayPAT's Licensee Scintomics signed Sub-License Agreement
BayPAT out-licenses three novel radioligands to Scintomics

Dec 7, 2017

BayPAT out-licenses three novel radioligands to Scintomics
Startup Company Bitflux acquires technology from BayPAT

Jul 11, 2017

Startup Company Bitflux acquires technology from BayPAT
License for indoor navigation

May 15, 2014

License for indoor navigation

Interested? Get in touch!

Contact a specific team member for individual topics via the Team section or simply use our contact form. You can also click on the button and drop us a line.

Contact us

Bayerische Patentallianz GmbH
Prinzregentenstr. 52
80538 München

Tel: +49 (0) 89 5480177 - 0
Fax: +49 (0) 89 5480177 - 99
E-Mail: kontakt@baypat.de

© Copyright 2020 • Bayerische Patentallianz GmbH • All rights reserved